Read More 5 minute read Pharma Industry News GLP-1 crackdown intensifies: What FDA’s new green list means for tirzepatide safety The FDA’s new GLP-1 green list aims to block illegal semaglutide and tirzepatide imports. Find out how it could reshape the compounding pharmacy landscape. byPallavi MadhirajuSeptember 7, 2025